Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lanthanum ruthenium indide, La(21)Ru(9+x)In(5-x) (x = 1.2).

ABSTRACT: La(21)Ru(9+x)In(5-x) (Pearson symbol tI140) is isotypic to the filled Y(3)Rh(2)-type structure, from which it can be derived through an ordered substitution at two sites. One of the square-prismatic sites (site symmetry ..m) is occupied by a mixture of Ru and In atoms and one of the square-antiprismatic sites (4/m..) is fully occupied by In atoms.

SUBMITTER: Tursina AI

PROVIDER: S-EPMC2979065 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Lanthanum ruthenium indide, La(21)Ru(9+x)In(5-x) (x = 1.2).

Tursina Anna I AI Cherviakov Sergei G SG Noël Henri H Chernyshev Vladimir V VV Seropegin Yuri D YD

Acta crystallographica. Section E, Structure reports online 20100424 Pt 5

La(21)Ru(9+x)In(5-x) (Pearson symbol tI140) is isotypic to the filled Y(3)Rh(2)-type structure, from which it can be derived through an ordered substitution at two sites. One of the square-prismatic sites (site symmetry ..m) is occupied by a mixture of Ru and In atoms and one of the square-antiprismatic sites (4/m..) is fully occupied by In atoms. ...[more]

PMID: 21578987

Similar Datasets

The lanthanum(III) molybdate(VI) La(4)Mo(7)O(27).

Project description:Crystals of the ortho-rhom-bic phase La(4)Mo(7)O(27) (lanthanum molybdenum oxide) were obtained from a non-stoichiometric melt in the pseudo-ternary system La(2)O(3)-MoO(3)-B(2)O(3). In the crystal structure, distorted square-anti-prismatic [LaO(8)] and monocapped square-anti-prismatic [LaO(9)] polyhedra are connected via common edges and faces into chains along [010]. These chains are arranged in layers that alternate with layers of [MoO(4)] and [MoO(5)] polyhedra parallel to (001). In the molybdate layers, a distorted [MoO(5)] trigonal bipyramid is axially connected to two [MoO(4)] tetra-hedra, forming a [Mo(3)O(11)] unit.

| S-EPMC2977117 | biostudies-literature

Ba(11)La(4)Br(34): a new barium lanthanum bromide.

Project description:The structure of the title compound, barium lanthanum bromide (11/4/34), can be derived from the fluorite structure. The asymmetric unit contains two Ba sites (one with site symmetry 4/m..), one La site (site symmetry 4..), one mixed-occupied Ba and La site (ratio 1:1, site symmetry m..) and six Br sites (one with site symmetry \=4.., one with 2.., one with m.., the latter being disordered over two positions with a 0.86:0.14 ratio). The fundamental building units of the structure are edge-sharing polyhedral clusters made up of Ba and La bromide clusters inter-connected to BaBr(8) square prisms and BaBr(10) groups.

| S-EPMC3201288 | biostudies-literature

The defect scheelite-type lanthanum(III) ortho-oxidomolybdate(VI) La(0.667)[MoO(4)].

Project description:In scheelite-type La(0.667)[MoO(4)], one crystallographically unique position with site symmetry -4.. and an occupancy of 2/3 is found for the La(3+) cation. The cation is surrounded by eight O atoms in the shape of a trigonal dodeca-hedron. The structure also contains one [MoO(4)](2-) anion (site symmetry -4..), which is surrounded by eight vertex-attached La(3+) cations. The polyhedra around the La(3+) cations are inter-connected via common edges, building up a three-dimensional network, in the tetra-hedral voids of which the Mo(6+) cations reside.

| S-EPMC3569171 | biostudies-literature

Crystal structure of La24Ru11.

Project description:The compound La24Ru11 (tetra-cosa-lanthanum undeca-ruthenium) crystallizes in a Ce24Co11-type structure. The non-centrosymmetric crystal structure (space group P63 mc) contains RuLa6 trigonal prisms, La6 octa-hedra and LaRu4 tetra-hedra and is closely related to that of Ce23Ni7Mg4. This communication highlights the crystal-chemical similarities and points out the differences between the two structures. All of the tested crystals were inversion twins.

| S-EPMC7405562 | biostudies-literature

trans-Di-?-carbonyl-bis-{carbon-yl[?-2,3,4,5-tetra-methyl-1-(2-thien-yl)cyclo-penta-dien-yl]ruthenium(I)}(Ru-Ru).

Project description:The title compound, [Ru(2)(C(13)H(15)S)(2)(CO)(4)], is a centrosymmetric binuclear metal-carbonyl complex containing an Ru-Ru single bond [2.7511?(8)?Å]. Each Ru(I) atom is coordinated by two bridging carbonyl ligands, one terminal carbonyl ligand and one ?(5)-cyclo-penta-dienyl group. The complex has a trans conformation and the two cyclo-penta-dienyl ring planes are parallel. The crystal structure involves weak C-H?O hydrogen bonds.

| S-EPMC2977155 | biostudies-other

Tetra-μ-acetato-κO:O'-bis-[(3-cyano-pyridine-κN)ruthenium(II,III)](Ru-Ru) hexa-fluoridophosphate 1,2-dichloro-ethane monosolvate.

Project description:The title compound, [Ru(2)(CH(3)CO(2))(4)(C(6)H(4)N(2))(2)]PF(6)·C(2)H(4)Cl(2), was obtained via a rapid substitution reaction in 2-propanol whereby 3-cyano-pyridine replaces the axial water mol-ecules in the diaquatetra-μ-acetato-diruthenium(II,III) hexa-fluorido-phosphate starting material. The product rapidly precipated and crystals were grown from 1,2-dichloro-ethane. The 1,2-dichloro-ethane mol-ecule of solvation exhibits disorder with two different orientations [occupancy ratio 0.51 (6):0.49 (6)]. All three parts, the cation, the anion and the disordered solvent mol-ecule lie on crystallographic inversion centers. The Ru-Ru bond length of 2.2702 (6) Å fits nicely into the range seen for similar complexes and correlates well with the reduction potential of the complex and donor strength of the axial ligand, 3-cyano-pyridine, as postulated in a previous study [Vamvounis et al. (2000 ▶). Inorg. Chim. Acta, 305, 87-98]. The 3-cyano-pyridine ligands orient themselves in an anti configuration with respect to each other and the Ru-Ru-N angle [174.27 (7)°] is close to being linear.

| S-EPMC3246975 | biostudies-literature

Recognizing and stabilizing miR-21 by chiral ruthenium(II) complexes.

Project description:MiR-21, a non-coding miRNA with 22 nucleotides, plays an important part in the proliferation, invasion, and metastasis of tumor cells. The present study demonstrates that isomers of chiral ruthenium(II) complexes with alkynes (Λ-1 and Δ-1) were synthesized by Songogashira coupling reaction by using microwave-assisted synthetic technology. The isomers can recognize and stabilize miR-21, with the Λ-isomer showing a stronger binding capacity than the Δ-isomer. Further studies showed that both isomers can be uptaken by MDA-MB-231 cells and enriched in the nucleus. Treatment with the Λ-/Δ-isomer downregulated the expression of miR-21. In a word, the development of chiral ruthenium(II) complexes act as potential inhibitors against tumor cells by recognizing, stabilizing, and regulating the expression of miR-21.

| S-EPMC7119291 | biostudies-literature

In situ investigation of ruthenium doped lanthanum nickel titanium double perovskite and its exsolution behaviour.

Project description:Exsolution, an innovative method for fabricating perovskite-based oxides decorated with metal nanoparticles, has garnered significant interest in the fields of catalyst fabrication and electrochemical devices. Although dopant exsolution from single perovskite structures has been extensively studied, the exsolution behaviour of double perovskite structures remains insufficiently understood. In this study, we synthesized B-site double perovskite Ru-doped lanthanum nickel titanates with a 7.5 at% A-site deficiency, and systematically investigated the exsolution process that formed nickel metal nanoparticles on the material surface, across a broad reduction temperature range of 350-1000 °C. Both Ex situ and in situ characterization revealed that small, uniform Ni nanoparticles exsolved at low temperatures, whereas the exsolution of ruthenium required higher reduction temperatures beyond 1000 °C. Within the reduction temperature range of 350-500 °C, a notable finding is the reconstruction of exsolved nanoparticles, implying that Ni particles exist in a thermodynamically metastable state. Electrochemical impedance spectroscopy (EIS) showed a decreased area specific resistance (ASR) during the progress of exsolution. The increase in current density of a full solid oxide cell (SOC) in electrolysis mode and the doubling of peak power density in fuel cell mode attributed to the exsolution of Ni nanoparticles highlight the potential application of metal exsolution in electrode materials for SOCs.

| S-EPMC11334975 | biostudies-literature

trans-Di-?-carbonyl-bis-{carbon-yl[?-2,3,4,5-tetra-methyl-1-(5-methyl-2-fur-yl)cyclo-penta-dien-yl]ruthenium(I)}(Ru-Ru).

Project description:In the crystal structure of the title compound, [Ru(2)(C(14)H(17)O)(2)(CO)(4)], each Ru(I) atom is connected to one end-on and two bridging carbonyl groups and one cyclo-penta-dienyl ring. The two Ru atoms are connected into binuclear complexes via two bridging carbonyl groups, forming four-membered rings which are located on centres of inversion. The Ru-Ru distance of 2.7483?(11)?Å corresponds to a single bond. The two carbonyl groups in these binuclear complexes are trans-oriented.

| S-EPMC2977131 | biostudies-literature

Determining the maximum lanthanum incorporation in the fluorite structure of La-doped ceria nanocubes for enhanced redox ability.

Project description:Ceria nanocubes have been doped with increasing amounts of lanthanum to enhance their redox ability. X-ray diffraction and transmission electron microscopy techniques provide a consistent picture indicating that there is an upper limit to the lanthanum that can be incorporated in the fluorite structure of ceria nanocubes, which is close to 7.5 mol% La. This limited loading is nevertheless able to produce a significant enhancement of the ceria redox ability as evidenced by use of X-ray absorption spectroscopy to determine the Ce3+/Ce4+ ratio in samples submitted to a degassing treatment at room temperature.

| S-EPMC9061073 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data